These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25917631)

  • 1. New York esophageal squamous cell carcinoma-1 and cancer immunotherapy.
    Esfandiary A; Ghafouri-Fard S
    Immunotherapy; 2015; 7(4):411-39. PubMed ID: 25917631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
    Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
    Front Immunol; 2018; 9():947. PubMed ID: 29770138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [NY-ESO-1 and cancer immunotherapy].
    Peng JR; Leng XS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):371-7. PubMed ID: 18795604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NY-ESO-1 expression and immunogenicity in esophageal cancer.
    Fujita S; Wada H; Jungbluth AA; Sato S; Nakata T; Noguchi Y; Doki Y; Yasui M; Sugita Y; Yasuda T; Yano M; Ono T; Chen YT; Higashiyama M; Gnjatic S; Old LJ; Nakayama E; Monden M
    Clin Cancer Res; 2004 Oct; 10(19):6551-8. PubMed ID: 15475443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NY-ESO-1 expression and its serum immunoreactivity in esophageal cancer.
    Akcakanat A; Kanda T; Koyama Y; Watanabe M; Kimura E; Yoshida Y; Komukai S; Nakagawa S; Odani S; Fujii H; Hatakeyama K
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):95-100. PubMed ID: 15118836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cancer-testis antigens in esophageal cancer and their progress in immunotherapy.
    Zhang Y; Zhang Y; Zhang L
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):281-291. PubMed ID: 30656409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NY-ESO-1 may be a potential target for lung cancer immunotherapy.
    Lee L; Wang RF; Wang X; Mixon A; Johnson BE; Rosenberg SA; Schrump DS
    Cancer J Sci Am; 1999; 5(1):20-5. PubMed ID: 10188057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1.
    Nicholaou T; Ebert L; Davis ID; Robson N; Klein O; Maraskovsky E; Chen W; Cebon J
    Immunol Cell Biol; 2006 Jun; 84(3):303-17. PubMed ID: 16681828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-testis antigen expression in digestive tract carcinomas: frequent expression in esophageal squamous cell carcinoma and its precursor lesions.
    Chen YT; Panarelli NC; Piotti KC; Yantiss RK
    Cancer Immunol Res; 2014 May; 2(5):480-6. PubMed ID: 24795360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we consider cancer/testis antigens NY-ESO-1, MAGE-A4 and MAGE-A1 as potential targets for immunotherapy in vulvar squamous cell carcinoma?
    Sznurkowski JJ; Zawrocki A; Karczewska J; Emerich J; Biernat W
    Histopathology; 2011 Feb; 58(3):481-3. PubMed ID: 21323970
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of MAGE-A and NY-ESO-1 in Primary and Metastatic Cancers.
    Park TS; Groh EM; Patel K; Kerkar SP; Lee CC; Rosenberg SA
    J Immunother; 2016 Jan; 39(1):1-7. PubMed ID: 26641256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with NY-ESO-1 overlapping peptides mixed with Picibanil OK-432 and montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.
    Wada H; Isobe M; Kakimi K; Mizote Y; Eikawa S; Sato E; Takigawa N; Kiura K; Tsuji K; Iwatsuki K; Yamasaki M; Miyata H; Matsushita H; Udono H; Seto Y; Yamada K; Nishikawa H; Pan L; Venhaus R; Oka M; Doki Y; Nakayama E
    J Immunother; 2014; 37(2):84-92. PubMed ID: 24509171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of New York esophageal squamous cell carcinoma 1 and its association with Foxp3 and indoleamine-2,3-dioxygenase in microenvironment of nonsmall cell lung cancer.
    Wang H; Xia Y; Yu J; Guan H; Wu Z; Ban D; Wang M
    HLA; 2019 Jul; 94(1):39-48. PubMed ID: 30953385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers.
    Oshima Y; Shimada H; Yajima S; Nanami T; Matsushita K; Nomura F; Kainuma O; Takiguchi N; Soda H; Ueda T; Iizasa T; Yamamoto N; Yamamoto H; Nagata M; Yokoi S; Tagawa M; Ohtsuka S; Kuwajima A; Murakami A; Kaneko H
    J Gastroenterol; 2016 Jan; 51(1):30-4. PubMed ID: 25906289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas.
    Mashino K; Sadanaga N; Tanaka F; Yamaguchi H; Nagashima H; Inoue H; Sugimachi K; Mori M
    Br J Cancer; 2001 Sep; 85(5):713-20. PubMed ID: 11531257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
    Grah J; Samija M; Juretić A; Sarcević B; Sobat H
    Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses detected in urothelial carcinoma patients after vaccination with NY-ESO-1 protein plus BCG and GM-CSF.
    Sharma P; Bajorin DF; Jungbluth AA; Herr H; Old LJ; Gnjatic S
    J Immunother; 2008; 31(9):849-57. PubMed ID: 18833002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases.
    Kerkar SP; Wang ZF; Lasota J; Park T; Patel K; Groh E; Rosenberg SA; Miettinen MM
    J Immunother; 2016 May; 39(4):181-7. PubMed ID: 27070449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma: a prototype of cancer-testis antigen-expressing malignancies.
    Faramarzi S; Ghafouri-Fard S
    Immunotherapy; 2017 Oct; 9(13):1103-1113. PubMed ID: 29032737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening.
    Chen YT; Scanlan MJ; Sahin U; Türeci O; Gure AO; Tsang S; Williamson B; Stockert E; Pfreundschuh M; Old LJ
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1914-8. PubMed ID: 9050879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.